MX2023004854A - Composicion para tratar enfermedades vasculares, composicion para evitar enfermedades vasculares, composicion para tratar hipertension y composicion para evitar hipertension. - Google Patents

Composicion para tratar enfermedades vasculares, composicion para evitar enfermedades vasculares, composicion para tratar hipertension y composicion para evitar hipertension.

Info

Publication number
MX2023004854A
MX2023004854A MX2023004854A MX2023004854A MX2023004854A MX 2023004854 A MX2023004854 A MX 2023004854A MX 2023004854 A MX2023004854 A MX 2023004854A MX 2023004854 A MX2023004854 A MX 2023004854A MX 2023004854 A MX2023004854 A MX 2023004854A
Authority
MX
Mexico
Prior art keywords
composition
preventing
vascular disease
hypertension
treating
Prior art date
Application number
MX2023004854A
Other languages
English (en)
Spanish (es)
Inventor
Kazuya Yamada
Nobuhiro Zaima
Chihiro Kishi
Yuki Takemoto
Shinichi Matsumura
Yuri Yoshioka
Kohei Iwamoto
Shohei Makino
Takanori Kobayashi
Original Assignee
Univ Kinki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kinki filed Critical Univ Kinki
Publication of MX2023004854A publication Critical patent/MX2023004854A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • A61K31/015Hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24DCIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES OF CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
    • A24D3/00Tobacco smoke filters, e.g. filter tips or filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces of cigars or cigarettes
    • A24D3/04Tobacco smoke filters characterised by their shape or structure
    • A24D3/048Tobacco smoke filters characterised by their shape or structure containing additives
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24DCIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES OF CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
    • A24D3/00Tobacco smoke filters, e.g. filter tips or filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces of cigars or cigarettes
    • A24D3/06Use of materials for tobacco smoke filters
    • A24D3/061Use of materials for tobacco smoke filters containing additives entrapped within capsules, sponge-like material or the like, for further release upon smoking
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24DCIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES OF CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
    • A24D3/00Tobacco smoke filters, e.g. filter tips or filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces of cigars or cigarettes
    • A24D3/06Use of materials for tobacco smoke filters
    • A24D3/062Use of materials for tobacco smoke filters characterised by structural features
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24DCIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES OF CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
    • A24D3/00Tobacco smoke filters, e.g. filter tips or filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces of cigars or cigarettes
    • A24D3/06Use of materials for tobacco smoke filters
    • A24D3/08Use of materials for tobacco smoke filters of organic materials as carrier or major constituent
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24DCIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES OF CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
    • A24D3/00Tobacco smoke filters, e.g. filter tips or filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces of cigars or cigarettes
    • A24D3/06Use of materials for tobacco smoke filters
    • A24D3/14Use of materials for tobacco smoke filters of organic materials as additive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/348Cannabaceae
    • A61K36/3482Cannabis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/348Cannabaceae
    • A61K36/3486Humulus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/67Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2023004854A 2020-11-06 2021-11-01 Composicion para tratar enfermedades vasculares, composicion para evitar enfermedades vasculares, composicion para tratar hipertension y composicion para evitar hipertension. MX2023004854A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063110506P 2020-11-06 2020-11-06
PCT/JP2021/040234 WO2022097601A1 (ja) 2020-11-06 2021-11-01 血管疾患治療用組成物、血管疾患予防用組成物、高血圧治療用組成物、及び高血圧予防用組成物

Publications (1)

Publication Number Publication Date
MX2023004854A true MX2023004854A (es) 2023-06-28

Family

ID=81457893

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023004854A MX2023004854A (es) 2020-11-06 2021-11-01 Composicion para tratar enfermedades vasculares, composicion para evitar enfermedades vasculares, composicion para tratar hipertension y composicion para evitar hipertension.

Country Status (11)

Country Link
US (1) US20230372262A1 (https=)
EP (1) EP4241768A4 (https=)
JP (1) JPWO2022097601A1 (https=)
KR (1) KR20230111206A (https=)
CN (1) CN116507220A (https=)
AR (1) AR124639A1 (https=)
MX (1) MX2023004854A (https=)
PY (1) PY2198298A (https=)
TW (1) TW202233167A (https=)
UY (1) UY39504A (https=)
WO (1) WO2022097601A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023042820A1 (ja) * 2021-09-14 2023-03-23 三生医薬株式会社 カリオフィレン含有組成物
MX2024002867A (es) * 2021-09-14 2024-03-22 Sunsho Pharmaceutical Co Ltd Composiciones que contienen cariofileno.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4280515A (en) * 1978-09-29 1981-07-28 International Flavors & Fragrances Inc. Use of a mixture of isomers of caryophyllene alcohol or dihydro caryophyllene alcohol in augmenting or enhancing the aroma or taste of smoking tobacco, smoking tobacco articles and/or smoking tobacco flavors
US5650232A (en) 1994-10-07 1997-07-22 Warner-Lambert Company Method for making seamless capsules
JP5116942B2 (ja) * 2003-04-22 2013-01-09 株式会社マザー&チャイルド プロジェステロンの変化に伴う不快症状の改善用組成物、及びその芳香治療用組成物、並びにその芳香治療用具
JP2004339154A (ja) * 2003-05-15 2004-12-02 Kazuyuki Shinohara 性欲促進用組成物
JP2005206520A (ja) * 2004-01-22 2005-08-04 Univ Kinki アテローム性動脈硬化抑制剤ならびにこれを含む食品および医薬
AU2008272135B2 (en) 2007-06-29 2013-10-31 Takeda Pharmaceutical Company Limited Seamless capsule
CN101249186A (zh) * 2008-03-18 2008-08-27 黄作秀 一种兼治外伤、风湿痛、牙痛的中药油剂及其生产方法
WO2013111281A1 (ja) * 2012-01-25 2013-08-01 日本たばこ産業株式会社 たばこ臭口臭改善香料組成物
JP5487227B2 (ja) * 2012-03-09 2014-05-07 株式会社 資生堂 ヒアルロン酸合成酵素遺伝子の発現促進剤
CN103141531B (zh) * 2013-03-07 2015-02-25 马氏兄弟科技(北京)股份有限公司 一种复方植物精油及其应用
WO2014170947A1 (ja) 2013-04-15 2014-10-23 三生医薬株式会社 崩壊可能なカプセル及びその製造方法並びに喫煙器具
WO2018094359A1 (en) * 2016-11-18 2018-05-24 Biotech Institute, Llc Caryophyllene compositions, apparatuses, and methods
CN111491525B (zh) * 2017-12-27 2022-04-26 日本烟草产业株式会社 吸烟物品
CN109613161A (zh) * 2018-12-27 2019-04-12 苏州科铭生物技术有限公司 一种基于顶空气相色谱法的β-石竹烯含量测定方法
JP6603817B1 (ja) * 2019-01-18 2019-11-06 三生医薬株式会社 シ−ムレスカプセルならびにこれを含むフィルターおよび喫煙器具

Also Published As

Publication number Publication date
TW202233167A (zh) 2022-09-01
PY2198298A (es) 2022-06-09
JPWO2022097601A1 (https=) 2022-05-12
CN116507220A (zh) 2023-07-28
EP4241768A4 (en) 2024-10-09
KR20230111206A (ko) 2023-07-25
UY39504A (es) 2022-05-31
AR124639A1 (es) 2023-04-19
EP4241768A1 (en) 2023-09-13
WO2022097601A1 (ja) 2022-05-12
US20230372262A1 (en) 2023-11-23

Similar Documents

Publication Publication Date Title
PH12022550932A1 (en) Glp-1r modulating compounds
PH12021552084A1 (en) Compounds, compositions, and methods for the treatment of disease
CR20240296A (es) Inhibidores parp1
PH12023552860A1 (en) Carboxy-benzimidazole glp-1r modulating compounds
UA130357C2 (uk) Карбоксибензімідазольні сполуки, які модулюють glp-1r
PH12020551995A1 (en) Modulator of apol1 expression
MX2023004854A (es) Composicion para tratar enfermedades vasculares, composicion para evitar enfermedades vasculares, composicion para tratar hipertension y composicion para evitar hipertension.
NZ758177A (en) Modulators of pcsk9 expression
MX2021010152A (es) Moduladores de la expresion de malat1.
ZA202200905B (en) Anti-egfr/anti-4-1bb bispecific antibody and use thereof
ZA202004848B (en) Modulators of irf4 expression
MX2023002851A (es) Tratamiento de la enfermedad de parkinson.
CL2021000107A1 (es) Métodos de tratamiento de hfpef empleando dapagliflozina y composiciones que comprenden la misma
MX2025000236A (es) Composiciones para el tratamiento de hipertension
EP3970793A4 (en) MEANS OF PREVENTING, IMPROVING OR TREATMENT OF PERIODONTAL DISEASES
PH12021552499A1 (en) Methods for the treatment of beta-thalassemia
ZA202207601B (en) Treatment of acute heart failure
MX2024012789A (es) Inhibidores de fosfoinositida 3-cinasa alfa (pi3kalfa)
BR112021017635A2 (pt) Composições e métodos para tratar a doença de huntington
EA202193121A1 (ru) Лечение рака
MX2023005171A (es) Composiciones y metodos para tratamiento de cancer solido.
EP4374917A3 (en) Formulations, methods, and systems for treating genitourinary conditions
WO2022268916A3 (en) Pan-coronavirus peptide vaccine
JOP20200217A1 (ar) مركب دوائي لعلاج فيروسات كورونا , خصوصا فيروس كوفيد-19
GEAP202516423A (en) Kcnv2 variants and their use